{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:42:00Z","timestamp":1781664120267,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.psc.2021.11.006","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:23:57Z","timestamp":1636676637000},"page":"95-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments"],"prefix":"10.1016","volume":"45","author":[{"given":"Osnat C.","family":"Melamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne K.","family":"deRuiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Selby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psc.2021.11.006_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/healthcare9010088","article-title":"A\u00a0case series: successfully preventing COVID-19 outbreak in a residential community setting at a drug and alcohol addiction treatment center","volume":"9","author":"Hanton","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.psc.2021.11.006_bib2","doi-asserted-by":"crossref","first-page":"108255","DOI":"10.1016\/j.jsat.2020.108255","article-title":"Impacts of COVID-19 on residential treatment programs for substance use disorder","volume":"123","author":"Pagano","year":"2020","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.psc.2021.11.006_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/jamapsychiatry.2020.4402","article-title":"Trends in US Emergency Department visits for mental health, overdose, and violence outcomes before and during the COVID-19 pandemic","volume":"78","author":"Holland","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psc.2021.11.006_bib4","doi-asserted-by":"crossref","first-page":"108260","DOI":"10.1016\/j.jsat.2020.108260","article-title":"Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California","volume":"123","author":"Herring","year":"2021","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"3","key":"10.1016\/j.psc.2021.11.006_bib5","doi-asserted-by":"crossref","first-page":"e210422","DOI":"10.1001\/jamanetworkopen.2021.0422","article-title":"Alcohol withdrawal rates in hospitalized patients during the COVID-19 pandemic","volume":"4","author":"Sharma","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"Suppl","key":"10.1016\/j.psc.2021.11.006_bib6","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.3122\/jabfm.2021.S1.200207","article-title":"Designing and evaluating COVID-19 protocols for an office-based opioid treatment program in an urban underserved setting","volume":"34","author":"O'Gurek","year":"2021","journal-title":"J\u00a0Am Board Fam Med"},{"issue":"2","key":"10.1016\/j.psc.2021.11.006_bib7","doi-asserted-by":"crossref","first-page":"E651","DOI":"10.9778\/cmajo.20210005","article-title":"Changes in family medicine visits across sociodemographic groups after the onset of the COVID-19 pandemic in Ontario: a retrospective cohort study","volume":"9","author":"Stephenson","year":"2021","journal-title":"CMAJ Open"},{"key":"10.1016\/j.psc.2021.11.006_bib8","series-title":"Facing addiction in America: the surgeon general's report on alcohol, drugs, and health","year":"2016"},{"issue":"4","key":"10.1016\/j.psc.2021.11.006_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/0098858817701962","article-title":"Combatting massachusetts's opioid epidemic: reducing the social stigma of addiction through increased access to voluntary treatment services and expansion of mandatory clinician education programs","volume":"42","author":"Pearlman","year":"2016","journal-title":"Am J Law Med"},{"issue":"2","key":"10.1016\/j.psc.2021.11.006_bib10","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13685","article-title":"Changes in diagnostic and demographic characteristics of patients seeking mental health care during the early COVID-19 pandemic in a large, community-based health care system","volume":"82","author":"Ridout","year":"2021","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.psc.2021.11.006_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.genhosppsych.2020.09.004","article-title":"Disparities in outpatient visits for mental health and\/or substance use disorders during the COVID surge and partial reopening in Massachusetts","volume":"67","author":"Yang","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.psc.2021.11.006_bib12","doi-asserted-by":"crossref","first-page":"113476","DOI":"10.1016\/j.psychres.2020.113476","article-title":"Mental health outcomes associated with the COVID-19 pandemic: Prevalence and risk factors in a southern US state","volume":"293","author":"Sherman","year":"2020","journal-title":"Psychiatry Res"},{"issue":"32","key":"10.1016\/j.psc.2021.11.006_bib13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","article-title":"Mental health, substance use, and suicidal ideation during the COVID-19 pandemic - United States, June 24-30, 2020","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.psc.2021.11.006_bib14","series-title":"Labour force survey, may 2020","author":"Statistics Canada","year":"2020"},{"issue":"1","key":"10.1016\/j.psc.2021.11.006_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00213-011-2183-x","article-title":"Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use","volume":"218","author":"Preston","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.psc.2021.11.006_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.psc.2021.11.006_bib17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.17269\/s41997-020-00434-y","article-title":"Changes in health behaviours during early COVID-19 and socio-demographic disparities: a cross-sectional analysis","volume":"111","author":"Zajacova","year":"2020","journal-title":"Can J Public Health"},{"key":"10.1016\/j.psc.2021.11.006_bib18","series-title":"COVID-19 national survey dashboard","year":"2021"},{"issue":"16","key":"10.1016\/j.psc.2021.11.006_bib19","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJMsr1503323","article-title":"Telehealth","volume":"377","author":"Tuckson","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.psc.2021.11.006_bib20","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1056\/NEJMp2003539","article-title":"Virtually Perfect? Telemedicine for Covid-19","volume":"382","author":"Hollander","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.psc.2021.11.006_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsat.2019.03.007","article-title":"Telemedicine-delivered treatment interventions for substance use disorders: A systematic review","volume":"101","author":"Lin","year":"2019","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.psc.2021.11.006_bib22","doi-asserted-by":"crossref","first-page":"108124","DOI":"10.1016\/j.jsat.2020.108124","article-title":"Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine","volume":"118","author":"Uscher-Pines","year":"2020","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.psc.2021.11.006_bib23","first-page":"100146","article-title":"Mental health services in primary care: Evidence for the feasibility of telehealth during the COVID-19 pandemic","volume":"5","author":"Frank","year":"2021","journal-title":"J\u00a0Affect Disord Rep"},{"issue":"12","key":"10.1016\/j.psc.2021.11.006_bib24","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1377\/hlthaff.2018.05134","article-title":"How Is Telemedicine Being Used In Opioid And Other Substance Use Disorder Treatment?","volume":"37","author":"Huskamp","year":"2018","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.psc.2021.11.006_bib25","unstructured":"Lowey NM. HR 6074-116th Congress (2019-2020): Coronavirus Preparedness and Response Supplemental Appropriations Act2020."},{"issue":"6","key":"10.1016\/j.psc.2021.11.006_bib26","first-page":"e366","article-title":"Telehealth capability among substance use disorder treatment facilities in counties with high versus low COVID-19 social distancing","volume":"14","author":"Cantor","year":"2020","journal-title":"J\u00a0Addict Med"},{"issue":"4","key":"10.1016\/j.psc.2021.11.006_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MLR.0000000000001512","article-title":"Availability of Outpatient Telemental Health Services in the United States at the Outset of the COVID-19 Pandemic","volume":"59","author":"Cantor","year":"2021","journal-title":"Med Care"},{"key":"10.1016\/j.psc.2021.11.006_bib28","doi-asserted-by":"crossref","first-page":"108462","DOI":"10.1016\/j.jsat.2021.108462","article-title":"Trends in visits to substance use disorder treatment facilities in 2020","volume":"127","author":"Cantor","year":"2021","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.psc.2021.11.006_bib29","doi-asserted-by":"crossref","first-page":"108215","DOI":"10.1016\/j.jsat.2020.108215","article-title":"Telehealth sustains patient engagement in OUD treatment during COVID-19","volume":"122","author":"Langabeer","year":"2021","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.psc.2021.11.006_bib30","article-title":"Impact of the coronavirus pandemic on substance use disorder treatment: findings from a survey of specialty providers in California","volume":"15","author":"Henretty","year":"2021","journal-title":"Subst Abuse"},{"issue":"5","key":"10.1016\/j.psc.2021.11.006_bib31","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ajog.2020.08.003","article-title":"Unintended consequences of the transition to telehealth for pregnancies complicated by opioid use disorder during the coronavirus disease 2019 pandemic","volume":"223","author":"McKiever","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.psc.2021.11.006_bib32","series-title":"Staying connected is important: virtual recovery resources","author":"Substance Abuse and Mental Health Services Administration","year":"2021"},{"issue":"6","key":"10.1016\/j.psc.2021.11.006_bib33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/alcalc\/agaa050","article-title":"Alcoholics anonymous and 12-step facilitation treatments for alcohol use disorder: a distillation of a 2020 cochrane review for clinicians and policy makers","volume":"55","author":"Kelly","year":"2020","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.psc.2021.11.006_bib34","article-title":"Canadians battling addiction in self-isolation turn to online AA meetings","author":"Couto","year":"2020","journal-title":"CTV News"},{"key":"10.1016\/j.psc.2021.11.006_bib35","doi-asserted-by":"crossref","first-page":"108393","DOI":"10.1016\/j.jsat.2021.108393","article-title":"The new services that opioid treatment programs have adopted in response to COVID-19","volume":"130","author":"Cantor","year":"2021","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.psc.2021.11.006_bib36","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s11606-020-06436-3","article-title":"COVID-19 adaptations in the care of patients with opioid use disorder: a survey of California primary care clinics","volume":"36","author":"Caton","year":"2021","journal-title":"J\u00a0Gen Intern Med"},{"issue":"1","key":"10.1016\/j.psc.2021.11.006_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12954-020-00370-7","article-title":"Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic","volume":"17","author":"Dunlop","year":"2020","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.psc.2021.11.006_bib38","series-title":"How to prescribe controlled substances to patients during the COVID-19 public health emergency","year":"2020"},{"key":"10.1016\/j.psc.2021.11.006_bib39","unstructured":"Lam V, Sankey C, Wyman J, Zhang M. COVID-19 opioid agonist treatment guidance: 2020. Available at: http:\/\/www.metaphi.ca\/wp-content\/uploads\/2021\/10\/COVID19_OpioidAgonistTreatmentGuidance.pdf. Accessed July 21, 2021."},{"key":"10.1016\/j.psc.2021.11.006_bib40","doi-asserted-by":"crossref","first-page":"108268","DOI":"10.1016\/j.jsat.2020.108268","article-title":"Increased availability of telehealth mental health and substance abuse treatment for peripartum and postpartum women: A unique opportunity to increase telehealth treatment","volume":"123","author":"Moreland","year":"2021","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.psc.2021.11.006_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7326\/M20-1212","article-title":"Collision of the COVID-19 and addiction epidemics","volume":"173","author":"Volkow","year":"2020","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.psc.2021.11.006_bib42","first-page":"e8","article-title":"Innovation during COVID-19: improving addiction treatment access","volume":"14","author":"Samuels","year":"2020","journal-title":"J\u00a0Addict Med"},{"issue":"1","key":"10.1016\/j.psc.2021.11.006_bib43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-020-00438-4","article-title":"Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic","volume":"17","author":"Castillo","year":"2020","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.psc.2021.11.006_bib44","doi-asserted-by":"crossref","first-page":"557275","DOI":"10.3389\/fpubh.2020.557275","article-title":"Patient satisfaction with medications for opioid use disorder treatment via telemedicine: brief literature review and development of a new assessment","volume":"8","author":"Cole","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.psc.2021.11.006_bib45","first-page":"1","article-title":"New approaches in drug dependence: opioids","author":"Mielau","year":"2021","journal-title":"Curr Addict Rep"},{"key":"10.1016\/j.psc.2021.11.006_bib46","first-page":"1","article-title":"Addressing the needs of older adults receiving alcohol treatment during the COVID-19 pandemic: a qualitative study","author":"Seddon","year":"2021","journal-title":"Aging Ment Health"},{"issue":"1","key":"10.1016\/j.psc.2021.11.006_bib47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jagp.2020.10.004","article-title":"Increasing participation in a substance misuse programs: lessons learned for implementing telehealth solutions during the COVID-19 pandemic","volume":"29","author":"Rosen","year":"2021","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.psc.2021.11.006_bib48","doi-asserted-by":"crossref","first-page":"108180","DOI":"10.1016\/j.jsat.2020.108180","article-title":"COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns","volume":"121","author":"Mellis","year":"2021","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"5","key":"10.1016\/j.psc.2021.11.006_bib49","first-page":"e139","article-title":"Policies to improve substance use disorder treatment with telehealth during the COVID-19 pandemic and beyond","volume":"14","author":"Drake","year":"2020","journal-title":"J\u00a0Addict Med"},{"issue":"3","key":"10.1016\/j.psc.2021.11.006_bib50","doi-asserted-by":"crossref","first-page":"e24850","DOI":"10.2196\/24850","article-title":"A\u00a0therapeutic relational agent for reducing problematic substance use (Woebot): development and usability study","volume":"23","author":"Prochaska","year":"2021","journal-title":"J\u00a0Med Internet Res"},{"issue":"2","key":"10.1016\/j.psc.2021.11.006_bib51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.psc.2012.03.009","article-title":"Advances in the psychosocial treatment of addiction: the role of technology in the delivery of evidence-based psychosocial treatment","volume":"35","author":"Marsch","year":"2012","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.psc.2021.11.006_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coisb.2020.07.004","article-title":"Digital Health and Addiction","volume":"20","author":"Marsch","year":"2020","journal-title":"Curr Opin Syst Biol"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X21000848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X21000848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:41:49Z","timestamp":1759282909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X21000848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0193953X21000848"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2021.11.006","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments","name":"articletitle","label":"Article Title"},{"value":"Psychiatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psc.2021.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}